Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.
about
Adverse events post smallpox-vaccination: insights from tail scarification infection in mice with Vaccinia virusVaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in miceSystemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Attenuation of vaccinia virus by the expression of human Flt3 ligandSmallpox vaccine with integrated IL-15 demonstrates enhanced in vivo viral clearance in immunodeficient mice and confers long term protection against a lethal monkeypox challenge in cynomolgus monkeys.Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.Transfected Plasmodium knowlesi produces bioactive host gamma interferon: a new perspective for modulating immune responses to malaria parasites.Expression of chicken interleukin-2 by a highly virulent strain of Newcastle disease virus leads to decreased systemic viral load but does not significantly affect mortality in chickens.Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in miceIL-15 as a mediator of CD4+ help for CD8+ T cell longevity and avoidance of TRAIL-mediated apoptosis.Vaccinia virus vaccines: past, present and future.Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.Oncolytic vaccinia virus for the treatment of cancer.Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.
P2860
Q27346800-48038C37-B176-4925-A247-00059E778956Q30375085-DA81AAE4-EAFE-49D6-9A27-8CC1A0FC3E98Q33479314-6AE32275-82AE-4468-B7CC-FCAF71EFC379Q33907236-7FDB91ED-1E9D-4CC1-8B85-D0C265BC6351Q34188464-BF9776BB-24AC-4A9D-B476-791839097429Q34869878-001A5A93-D957-47C3-ABCA-57808B7614CEQ35165305-04B055F4-AF0B-431F-BBD7-3A1961D761E4Q35927469-FB29CB60-C1BB-4650-9553-1C22768B4873Q35947780-B07CD1E5-DBFC-4D7E-B6F7-243DD1102E11Q36516239-342750E2-D8B3-4B70-BE5C-FD61D339B01EQ37343595-697B6DBC-5F0D-43A1-92AE-CEB96EA5FCB4Q37596586-6F2EF202-5677-497D-A379-32500DF58DF5Q37845399-4D8776DD-F823-49CC-9A42-C947667E50E4Q39995833-406A4249-6799-4A80-847D-D1965316D7A2
P2860
Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Comparative assessment of viru ...... IL-15 in immunodeficient mice.
@ast
Comparative assessment of viru ...... IL-15 in immunodeficient mice.
@en
type
label
Comparative assessment of viru ...... IL-15 in immunodeficient mice.
@ast
Comparative assessment of viru ...... IL-15 in immunodeficient mice.
@en
prefLabel
Comparative assessment of viru ...... IL-15 in immunodeficient mice.
@ast
Comparative assessment of viru ...... IL-15 in immunodeficient mice.
@en
P2093
P2860
P356
P1476
Comparative assessment of viru ...... IL-15 in immunodeficient mice.
@en
P2093
C K Goldman
L P Perera
T A Waldmann
P2860
P304
P356
10.1073/PNAS.081080298
P407
P577
2001-04-10T00:00:00Z